About Us


We aim to transform human health to enhance the quality of life and prevent diseases, via microbiome R&D advancements.

Our expert team of partners and talented scientists are passionate about bringing First-in-class cosmetics, nutraceuticals and pharmaceuticals to the market. Their work began with the discovery of probiotic species that produce Omegas 7 and 9, which now leads to the study of probiotic Omegas 3 and 6. Next, they also envisage exploring these molecules in innovative therapeutic compounds, and also materials of the future as requested by industry partners.

As advocates for the transformative power of pre, pro and post-biotics combined with Omega super nutrients, the BiomeMega team have been able to share this passion by creating carefully crafted, targeted formulas to help you feel your best.

Meet the Team

  • Dr Gustavo De Cerqueira

    CHIEF EXECUTIVE OFFICER

  • Dr Peter Valtchev

    SCIENCE & TECHNOLOGY ADVISOR

  • NON-EXECUTIVE CEO

    Honorary Affiliate at the University of Sydney.

    MD at Cluster Biotechnology.

    Venture Partner at Provisio Ventures.

    PhD in Biotechnology (Molecular Microbiology) and Masters in Agricultural Biotechnology.

    30+ papers in Molecular Microbiology and Biomedical Genomics.

    Inventor in Australian Patents and International provisional applications.

    Company Director with experience growing start-ups and scaleups.

    External Advisor at the University of the Sunshine Coast and James Cook University.

    Former lecturer in Microbiology & Immunology.

    International education at the Institute Pasteur (PhD jointly France-Brazil).

    Former visiting scientist at UCONN Health Center (Molecular Vaccinology).

    Former Rotaract member – Rotary International.

    Former postdoc at USyd (synbio), Monash University (molecular micro) and Butantan institute (molecular

    vaccinology).

  • SCIENCE & TECHNOLOGY ADVISOR

    PhD in Chemical and Biomolecular Engineering at the University of Sydney;

    Staff researcher at the University of Sydney, with a history of successful industry engagements;

    40+ papers in peer-reviewed International journals;

    Long-term experience in medical and pharmaceutical sciences;

    Strong career pathway in therapeutic drug monitoring and pharmaceutical R&D;

    Exceptional analytical background and interest in neutraceuticals, food and plant analysis, drug metabolism, pharmacokinetics, and bioavailability studies.